← Back to Patent Explorer
US4496548A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition and method for reducing hangover

Assignee: Individual
•
Filing: 1983-02-04
•
Granted: 1985-01-29
•
Expires: 2003-02-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel composition and method is disclosed for preventing hangover effects in humans caused by consumption of alcoholic beverages. The composition comprises thiamine, ascorbic acid, at least one of cystein or cysteic acid, and at least one flavonoid or flavonoid complex selected from hesperidin, rutin, and hesperidin-methyl-chalcone. Preferred administration is orally, before consumption of alcohol.

Inventors

  • 👤 Mervin J. Moldowan
  • 👤 Carol Moldowan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 16:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 69 words
A composition for reducing effects associated with the consumption of ethyl alcohol by humans comprising: (a) 12% to 80% by weight ascorbic acid; (b) 5% to 70% by weight thiamine; (c) 10% to 90% by weight of a compound selected from cysteine and cysteic acid; and (d) 1.5% to 85% by weight of a flavonoid or flavonoid complex selected from the group consisting essentially of rutin, hesperidin, and hesperidin-methyl-chalcone.
Claim 2
Dependent Claim 69 words
A composition for reducing effects associated with the consumption of ethyl alcohol by humans comprising: (a) 12% to 80% by weight ascorbic acid; (b) 5% to 70% by weight thiamine; (c) 10% to 90% by weight of a compound selected from cysteine and cysteic acid; and (d) 1.5% to 85% by weight of a flavonoid or flavonoid complex selected from the group consisting essentially of rutin, hesperidin, and hesperidin-methyl-chalcone.
Claim 3
Dependent Claim 72 words
The composition of claim 1 wherein ascorbic acid is present in an amount of from about 100 mg to about 5 grams, thiamine is present in an amount of from about 5 mg to about 1 gram, cysteine or cysteic acid is present in an amount of from about 10 mg to about 2 grams, and said flavonoid is present in an amount of from about 10 mg to about 1 gram.
Claim 4
Independent Claim 88 words
A method for reducing effects associated with the consumption of ethyl alcohol by humans, which comprises ingestion prior to, during, or immediately following consumption of ethyl alcohol, an effective amount of a composition comprising: (a) 12% to 80% by weight ascorbic acid; (b) 5% to 70% by weight thiamine; (c) 10% to 90% by weight of a compound selected from cysteine and cysteic acid; and (d) 1.5% to 85% by weight of a flavonoid or flavonoid complex selected from the group consisting essentially of rutin, hesperidin, and hesperidin-methyl-chalcone.
Claim 5
Independent Claim 88 words
A method for reducing effects associated with the consumption of ethyl alcohol by humans, which comprises ingestion prior to, during, or immediately following consumption of ethyl alcohol, an effective amount of a composition comprising: (a) 12% to 80% by weight ascorbic acid; (b) 5% to 70% by weight thiamine; (c) 10% to 90% by weight of a compound selected from cysteine and cysteic acid; and (d) 1.5% to 85% by weight of a flavonoid or flavonoid complex selected from the group consisting essentially of rutin, hesperidin, and hesperidin-methyl-chalcone.
Claim 6
Dependent Claim 11 words
The method of claim 3 wherein said composition is ingested orally.
Claim 7
Dependent Claim 15 words
The method of claim 4 wherein said composition is ingested in the form of tablets.
Claim 8
Dependent Claim 32 words
The composition of claim 1 comprising 47% by weight ascorbic acid, 23% by weight thiamine, 5% by weight cysteine or cysteic acid, and 23% by weight of a flavonoid or flavonoid complex.
Claim 9
Dependent Claim 35 words
The method of claim 3 wherein said composition comprises 47% by weight ascorbic acid, 23% by weight thiamine, 5% by weight cysteine or cysteic acid, and 23% by weight of a flavonoid or flavonoid complex.

References Cited (Backward Citations)

US2962515A Cited
US3084154A Cited
US3346559A Cited
US3953423A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-01-29 1988-07-30 1989-01-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-01-29 1992-07-30 1993-01-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-01-29 1996-07-30 1997-01-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag